NCT07706322

Brief Summary

The purpose of this study is to adapt and pilot a sexual assault prevention intervention for transgender and nonbinary (trans) undergraduate students. Forty percent of trans individuals (i.e., individuals whose gender identity does not align with their sex assigned at birth, inclusive of nonbinary people) are sexually assaulted during their time in college. Despite the magnitude of this issue, there are no sexual assault prevention interventions that have lowered victimization of trans students. The Enhanced Assess, Acknowledge, Act (EAAA) intervention is recommended by the Centers for Disease Control and Prevention (CDC) and is the only intervention proven to lower rape victimization by over 50% among cisgender female undergraduates. However, trans-specific vulnerabilities to violence are not addressed in EAAA, nor in the online adaptation of EAAA recently piloted by the study team called internet-delivered EAAA (IDEA3). This project will adapt and pilot IDEA3 for trans and nonbinary students to develop one of the first evidence-based sexual assault prevention interventions for trans and nonbinary young adults. We will adapt IDEA3 for trans students ages 18-25 and test it in an initial group which we will use to make revisions to the program. Then, we will collect participant survey and focus group data on feasibility and acceptability from 4 more groups of participants, revising the intervention between groups. Finally, we will collect preliminary data on whether the program increased participants' confidence in their ability to defend themselves.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
9mo left

Started Sep 2026

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 10, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

July 15, 2026

Completed
2 months until next milestone

Study Start

First participant enrolled

September 2, 2026

Expected
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2027

1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2027

Last Updated

July 15, 2026

Status Verified

July 1, 2026

Enrollment Period

8 months

First QC Date

July 10, 2026

Last Update Submit

July 10, 2026

Conditions

Outcome Measures

Primary Outcomes (3)

  • Feasibility of TEA3 intervention

    This will be assessed by reviewing speed of recruitment and noting no-shows (at first session), overall session attendance, and retention rates for the online intervention to determine whether incentives are sufficient for a future larger trial; reviewing fidelity to the original intervention based on reviewing recordings of all online intervention sessions; reviewing and cataloging deviations from the manual; and final review of what pieces of TEA3 went well and what pieces need to be further adapted in the future.

    Within one week of the final intervention session

  • Acceptability of TEA3 intervention

    This will be assessed from summary statistics calculated from survey questions completed by participants relating to dimensions of affective attitude (how the individual feels about the intervention); burden (perceived effort required to participate); ethicality (extent to which the intervention fits with the individual's value system), perceived effectiveness, and whether they would recommend the intervention to a friend.

    Within one week of the final intervention session

  • Intervention participants' self-defense self-efficacy

    This will be assessed from participant answers to baseline and post-test surveys that use validated scales to measure self-defense self-efficacy (i.e. confidence that one could defend oneself against sexual assault)

    Within one week of the final intervention session

Secondary Outcomes (1)

  • Efficacy of TEA3 intervention

    Within one week of the final intervention session

Study Arms (1)

TEA3 Intervention

EXPERIMENTAL
Other: TEA3 Intervention

Interventions

Delivery of TEA3 intervention, a 15-hour online sexual assault resistance intervention for transgender undergraduates.

TEA3 Intervention

Eligibility Criteria

Age18 Years - 25 Years
Sexall(Gender-based eligibility)
Gender Eligibility DetailsThis study is designed specifically for undergraduates who identify as trans or nonbinary.
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Participants must be adults ages 18 to 25, AND
  • Have a gender identity that differs from their sex assigned at birth (e.g. trans or nonbinary) AND
  • Be an undergraduate student AND
  • Be available during the program times, AND
  • Provide the contact information for another trans or nonbinary undergraduate who they would be willing to participate in the intervention with OR express willingness to being partnered with another trans or nonbinary undergraduate at their university AND
  • Have access to and willingness to use the videoconferencing software Zoom for the program AND
  • Consent to being recorded while participating.

You may not qualify if:

  • Participant is less than 18 years of age or older than 25 years of age, OR
  • Does not identify as a trans or nonbinary individual, OR
  • Is not an undergraduate student, OR
  • Is not available during the program times, OR
  • Does not provide the contact information for another trans or nonbinary undergraduate student who they would be willing to participate in the intervention with AND does not express a willingness to being partnered with another undergraduate OR
  • Does not have access to and or is unwilling to use the videoconferencing software Zoom, OR
  • Does not consent to being recorded while participating.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Peitzmeier SM, Ashwell L, Adams MP, Edwards K, Senn CY. The IDEA3 pilot trial: feasibility, acceptability, and preliminary efficacy of an online adaptation of an evidence-based intervention for campus sexual assault prevention. BMC Womens Health. 2026 Jun 3. doi: 10.1186/s12905-026-04551-7. Online ahead of print.

    PMID: 42237318BACKGROUND

Study Officials

  • Sarah Peitzmeier, PhD

    University of Maryland, College Park

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Sarah Peitzmeier, PhD

CONTACT

Michelle Choi, MA

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

July 10, 2026

First Posted

July 15, 2026

Study Start (Estimated)

September 2, 2026

Primary Completion (Estimated)

April 30, 2027

Study Completion (Estimated)

June 1, 2027

Last Updated

July 15, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share

Data from video recordings contain identifiers including participant images and names which cannot be removed, and will therefore remain non-public. Deidentified survey data from initial screener surveys can be made available upon reasonable request and with IRB approval.